Cargando…
Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620557/ https://www.ncbi.nlm.nih.gov/pubmed/36951158 http://dx.doi.org/10.3324/haematol.2022.282478 |
| _version_ | 1785130231209656320 |
|---|---|
| author | Capecchi, Marco De Leo, Pasqualina Abbattista, Maria Mancini, Ilaria Agosti, Pasquale Biganzoli, Marina Suffritti, Chiara Ferrari, Barbara Lecchi, Anna La Marca, Silvia Padovan, Lidia Scalambrino, Erica Clerici, Marigrazia Tripodi, Armando Artoni, Andrea Gualtierotti, Roberta Peyvandi, Flora |
| author_facet | Capecchi, Marco De Leo, Pasqualina Abbattista, Maria Mancini, Ilaria Agosti, Pasquale Biganzoli, Marina Suffritti, Chiara Ferrari, Barbara Lecchi, Anna La Marca, Silvia Padovan, Lidia Scalambrino, Erica Clerici, Marigrazia Tripodi, Armando Artoni, Andrea Gualtierotti, Roberta Peyvandi, Flora |
| author_sort | Capecchi, Marco |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10620557 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106205572023-11-03 Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients Capecchi, Marco De Leo, Pasqualina Abbattista, Maria Mancini, Ilaria Agosti, Pasquale Biganzoli, Marina Suffritti, Chiara Ferrari, Barbara Lecchi, Anna La Marca, Silvia Padovan, Lidia Scalambrino, Erica Clerici, Marigrazia Tripodi, Armando Artoni, Andrea Gualtierotti, Roberta Peyvandi, Flora Haematologica Letter to the Editor Fondazione Ferrata Storti 2023-03-23 /pmc/articles/PMC10620557/ /pubmed/36951158 http://dx.doi.org/10.3324/haematol.2022.282478 Text en Copyright© 2023 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letter to the Editor Capecchi, Marco De Leo, Pasqualina Abbattista, Maria Mancini, Ilaria Agosti, Pasquale Biganzoli, Marina Suffritti, Chiara Ferrari, Barbara Lecchi, Anna La Marca, Silvia Padovan, Lidia Scalambrino, Erica Clerici, Marigrazia Tripodi, Armando Artoni, Andrea Gualtierotti, Roberta Peyvandi, Flora Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients |
| title | Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients |
| title_full | Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients |
| title_fullStr | Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients |
| title_full_unstemmed | Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients |
| title_short | Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients |
| title_sort | risk of relapse after sars-cov-2 vaccine in the milan cohort of thrombotic thrombocytopenic purpura patients |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620557/ https://www.ncbi.nlm.nih.gov/pubmed/36951158 http://dx.doi.org/10.3324/haematol.2022.282478 |
| work_keys_str_mv | AT capecchimarco riskofrelapseaftersarscov2vaccineinthemilancohortofthromboticthrombocytopenicpurpurapatients AT deleopasqualina riskofrelapseaftersarscov2vaccineinthemilancohortofthromboticthrombocytopenicpurpurapatients AT abbattistamaria riskofrelapseaftersarscov2vaccineinthemilancohortofthromboticthrombocytopenicpurpurapatients AT manciniilaria riskofrelapseaftersarscov2vaccineinthemilancohortofthromboticthrombocytopenicpurpurapatients AT agostipasquale riskofrelapseaftersarscov2vaccineinthemilancohortofthromboticthrombocytopenicpurpurapatients AT biganzolimarina riskofrelapseaftersarscov2vaccineinthemilancohortofthromboticthrombocytopenicpurpurapatients AT suffrittichiara riskofrelapseaftersarscov2vaccineinthemilancohortofthromboticthrombocytopenicpurpurapatients AT ferraribarbara riskofrelapseaftersarscov2vaccineinthemilancohortofthromboticthrombocytopenicpurpurapatients AT lecchianna riskofrelapseaftersarscov2vaccineinthemilancohortofthromboticthrombocytopenicpurpurapatients AT lamarcasilvia riskofrelapseaftersarscov2vaccineinthemilancohortofthromboticthrombocytopenicpurpurapatients AT padovanlidia riskofrelapseaftersarscov2vaccineinthemilancohortofthromboticthrombocytopenicpurpurapatients AT scalambrinoerica riskofrelapseaftersarscov2vaccineinthemilancohortofthromboticthrombocytopenicpurpurapatients AT clericimarigrazia riskofrelapseaftersarscov2vaccineinthemilancohortofthromboticthrombocytopenicpurpurapatients AT tripodiarmando riskofrelapseaftersarscov2vaccineinthemilancohortofthromboticthrombocytopenicpurpurapatients AT artoniandrea riskofrelapseaftersarscov2vaccineinthemilancohortofthromboticthrombocytopenicpurpurapatients AT gualtierottiroberta riskofrelapseaftersarscov2vaccineinthemilancohortofthromboticthrombocytopenicpurpurapatients AT peyvandiflora riskofrelapseaftersarscov2vaccineinthemilancohortofthromboticthrombocytopenicpurpurapatients |